422 related articles for article (PubMed ID: 18366449)
1. Causes of the first AIDS-defining illness and subsequent survival before and after the advent of combined antiretroviral therapy.
Grabar S; Lanoy E; Allavena C; Mary-Krause M; Bentata M; Fischer P; Mahamat A; Rabaud C; Costagliola D;
HIV Med; 2008 Apr; 9(4):246-56. PubMed ID: 18366449
[TBL] [Abstract][Full Text] [Related]
2. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
Ives NJ; Gazzard BG; Easterbrook PJ
J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
[TBL] [Abstract][Full Text] [Related]
3. Evolving trends revealed by autopsies of patients with the acquired immunodeficiency syndrome. 565 autopsies in adults with the acquired immunodeficiency syndrome, Los Angeles, Calif, 1982-1993 [corrected].
Klatt EC; Nichols L; Noguchi TT
Arch Pathol Lab Med; 1994 Sep; 118(9):884-90. PubMed ID: 8080357
[TBL] [Abstract][Full Text] [Related]
4. [AIDS with inaugural Pneumocystis pneumonia pneumonia. Impact of triple antiretroviral therapy].
Yousfi M; Boibieux A; Bouhour D; Biron F; Chidiac C; Peyramond D
Pathol Biol (Paris); 1999 May; 47(5):566-9. PubMed ID: 10418042
[TBL] [Abstract][Full Text] [Related]
5. HIV-associated Isospora belli infection: incidence and risk factors in the French Hospital Database on HIV.
Guiguet M; Furco A; Tattevin P; Costagliola D; Molina JM;
HIV Med; 2007 Mar; 8(2):124-30. PubMed ID: 17352769
[TBL] [Abstract][Full Text] [Related]
6. HIV infection and AIDS.
Lloyd A
P N G Med J; 1996 Sep; 39(3):174-80. PubMed ID: 9795558
[TBL] [Abstract][Full Text] [Related]
7. Opportunistic infections and other AIDS-defining illnesses in Poland in 2000-2002.
Podlasin RB; Wiercinska-Drapalo A; Olczak A; Beniowski M; Smiatacz T; Malolepsza E; Juszczyk J; Leszczyszyn-Pynka M; Mach T; Mian M; Knysz B; Horban A
Infection; 2006 Aug; 34(4):196-200. PubMed ID: 16896577
[TBL] [Abstract][Full Text] [Related]
8. Maintaining antiretroviral therapy reduces the risk of AIDS-defining events in patients with uncontrolled viral replication and profound immunodeficiency.
Kousignian I; Abgrall S; Grabar S; Mahamat A; Teicher E; Rouveix E; Costagliola D;
Clin Infect Dis; 2008 Jan; 46(2):296-304. PubMed ID: 18171266
[TBL] [Abstract][Full Text] [Related]
9. Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998.
Louie JK; Hsu LC; Osmond DH; Katz MH; Schwarcz SK
J Infect Dis; 2002 Oct; 186(7):1023-7. PubMed ID: 12232845
[TBL] [Abstract][Full Text] [Related]
10. Long-term exposure to combination antiretroviral therapy and risk of death from specific causes: no evidence for any previously unidentified increased risk due to antiretroviral therapy.
Kowalska JD; Reekie J; Mocroft A; Reiss P; Ledergerber B; Gatell J; d'Arminio Monforte A; Phillips A; Lundgren JD; Kirk O;
AIDS; 2012 Jan; 26(3):315-23. PubMed ID: 22112597
[TBL] [Abstract][Full Text] [Related]
11. HIV infection/acquired immunodeficiency syndrome at Siriraj Hospital, 2002: time for secondary prevention.
Anekthananon T; Ratanasuwan W; Techasathit W; Rongrungruang Y; Suwanagool S
J Med Assoc Thai; 2004 Feb; 87(2):173-9. PubMed ID: 15061301
[TBL] [Abstract][Full Text] [Related]
12. Impact of pregnancy on maternal AIDS.
Kumar RM; Uduman SA; Khurrana AK
J Reprod Med; 1997 Jul; 42(7):429-34. PubMed ID: 9252934
[TBL] [Abstract][Full Text] [Related]
13. Comparing the first and second hundred AIDS cases in Hong Kong.
Wong KH; Lee SS
Singapore Med J; 1998 Jun; 39(6):236-40. PubMed ID: 9803809
[TBL] [Abstract][Full Text] [Related]
14. AIDS-defining illness diagnosed within 90 days after starting highly active antiretroviral therapy among patients from the TREAT Asia HIV Observational Database.
Zhou J; Paton NI; Ditangco R
Int J STD AIDS; 2007 Jul; 18(7):446-52. PubMed ID: 17623500
[TBL] [Abstract][Full Text] [Related]
15. [Effectiveness of combined antiretroviral therapy on multiple AIDS-defining illnesses in an HIV seroconverter cohort].
Ferreros I; Hurtado I; del Amo J; Muga R; del Romero J; García P; Alastrué I; Belda J; Guevara M; Pérez S;
Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):179-84. PubMed ID: 21333403
[TBL] [Abstract][Full Text] [Related]
16. Mental health disorders and the risk of AIDS-defining illness and death in HIV-infected veterans.
Nurutdinova D; Chrusciel T; Zeringue A; Scherrer JF; Al-Aly Z; McDonald JR; Overton ET
AIDS; 2012 Jan; 26(2):229-34. PubMed ID: 22089375
[TBL] [Abstract][Full Text] [Related]
17. [Epidemiological and clinical characteristics of HIV/AIDS patients followed-up in Cappadocia region: 18 years experience].
Alp E; Bozkurt I; Doğanay M
Mikrobiyol Bul; 2011 Jan; 45(1):125-36. PubMed ID: 21341167
[TBL] [Abstract][Full Text] [Related]
18. Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study.
Khanna N; Elzi L; Mueller NJ; Garzoni C; Cavassini M; Fux CA; Vernazza P; Bernasconi E; Battegay M; Hirsch HH;
Clin Infect Dis; 2009 May; 48(10):1459-66. PubMed ID: 19348592
[TBL] [Abstract][Full Text] [Related]
19. Risk of cancers during interrupted antiretroviral therapy in the SMART study.
Silverberg MJ; Neuhaus J; Bower M; Gey D; Hatzakis A; Henry K; Hidalgo J; Lourtau L; Neaton JD; Tambussi G; Abrams DI
AIDS; 2007 Sep; 21(14):1957-63. PubMed ID: 17721103
[TBL] [Abstract][Full Text] [Related]
20. Differential impact of combination antiretroviral therapy in preventing Kaposi's sarcoma with and without visceral involvement.
Grabar S; Abraham B; Mahamat A; Del Giudice P; Rosenthal E; Costagliola D
J Clin Oncol; 2006 Jul; 24(21):3408-14. PubMed ID: 16849755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
